U.S. Humira Market Size & Outlook, 2025-2030
Related Markets
U.S. humira market highlights
- The U.S. humira market generated a revenue of USD 7,379.3 million in 2024 and is expected to reach USD 2,578.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of -13% from 2025 to 2030.
- In terms of segment, branded was the largest revenue generating type in 2024.
- Biosimilar is the most lucrative type segment registering the fastest growth during the forecast period.
Humira market data book summary
| Market revenue in 2024 | USD 7,379.3 million |
| Market revenue in 2030 | USD 2,578.3 million |
| Growth rate | -13% (CAGR from 2025 to 2030) |
| Largest segment | Branded |
| Fastest growing segment | Biosimilar |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Branded, Biosimilar |
Other key industry trends
- In terms of revenue, U.S. accounted for 71.4% of the global humira market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. humira market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 16.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Humira Market Scope
Humira Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sandoz | View profile | 10001+ | Holzkirchen, Bayern, Germany, Europe | https://www.sandoz.de |
| Alvotech | View profile | 999 | 9, rue de Bitbourg, Luxembourg, Luxembourg, L-1273 | https://www.alvotech.com |
| Boehringer Ingelheim Pharma | View profile | 10001+ | Dortmund, Nordrhein-Westfalen, Germany, Europe | https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund |
| Coherus BioSciences Inc | View profile | 306 | 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, United States, 94065 | https://www.coherus.com |
| Samsung Bioepis | View profile | 501-1000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbioepis.com |
| Celltrion Healthcare | View profile | 51-100 | Incheon, Inch'on-jikhalsi, South Korea, Asia | http://www.celltrionhealthcare.com/ |
| Fresenius Kabi | View profile | 10001+ | Bad Homburg, Hessen, Germany, Europe | https://www.fresenius-kabi.se |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
U.S. humira market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to humira market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 56.65% in 2024. Horizon Databook has segmented the U.S. humira market based on branded, biosimilar covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. humira market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. humira market databook
-
Our clientele includes a mix of humira market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. humira market , including forecasts for subscribers. This country databook contains high-level insights into U.S. humira market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
US Type - Humira Market size, 2024 - 2030 (US$M)
U.S. Humira Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
